vs
ALKAMI TECHNOLOGY, INC.（ALKT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
ALKAMI TECHNOLOGY, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$126.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -7.9%，领先391.9%），ALKAMI TECHNOLOGY, INC.同比增速更快（28.9% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 23.9%）
Alkami科技是一家面向美国市场的云原生数字银行解决方案提供商，主要为社区银行、信用合作社等金融机构提供在线及移动银行系统、支付处理工具、数据分析模块与客户互动功能，助力合作机构优化终端用户的数字银行使用体验。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ALKT vs RIGL — 直观对比
营收规模更大
ALKT
是对方的1.8倍
$69.8M
营收增速更快
ALKT
高出7.7%
21.2%
净利率更高
RIGL
高出391.9%
-7.9%
两年增速更快
RIGL
近两年复合增速
23.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.1M | $69.8M |
| 净利润 | $-10.0M | $268.1M |
| 毛利率 | 58.6% | 91.5% |
| 营业利润率 | 36.9% | 33.2% |
| 净利率 | -7.9% | 384.0% |
| 营收同比 | 28.9% | 21.2% |
| 净利润同比 | -27.5% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKTRIGL
| Q1 26 | $126.1M | — | ||
| Q4 25 | $120.8M | $69.8M | ||
| Q3 25 | $113.0M | $69.5M | ||
| Q2 25 | $112.1M | $101.7M | ||
| Q1 25 | $97.8M | $53.3M | ||
| Q4 24 | $89.7M | $57.6M | ||
| Q3 24 | $85.9M | $55.3M | ||
| Q2 24 | $82.2M | $36.8M |
净利润ALKTRIGL
| Q1 26 | $-10.0M | — | ||
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-14.8M | $27.9M | ||
| Q2 25 | $-13.6M | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-9.4M | $12.4M | ||
| Q2 24 | $-12.3M | $-1.0M |
毛利率ALKTRIGL
| Q1 26 | 58.6% | — | ||
| Q4 25 | 57.2% | 91.5% | ||
| Q3 25 | 56.8% | 93.2% | ||
| Q2 25 | 58.6% | 95.6% | ||
| Q1 25 | 59.0% | 91.7% | ||
| Q4 24 | 59.3% | 89.9% | ||
| Q3 24 | 58.9% | 85.5% | ||
| Q2 24 | 59.4% | 92.4% |
营业利润率ALKTRIGL
| Q1 26 | 36.9% | — | ||
| Q4 25 | -7.9% | 33.2% | ||
| Q3 25 | -11.4% | 40.9% | ||
| Q2 25 | -14.2% | 60.1% | ||
| Q1 25 | -15.7% | 23.9% | ||
| Q4 24 | -9.6% | 28.9% | ||
| Q3 24 | -12.1% | 25.4% | ||
| Q2 24 | -16.1% | 1.2% |
净利率ALKTRIGL
| Q1 26 | -7.9% | — | ||
| Q4 25 | — | 384.0% | ||
| Q3 25 | -13.1% | 40.2% | ||
| Q2 25 | -12.1% | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -11.0% | 22.5% | ||
| Q2 24 | -15.0% | -2.8% |
每股收益（稀释后）ALKTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | $14.11 | ||
| Q3 25 | $-0.14 | $1.46 | ||
| Q2 25 | $-0.13 | $3.28 | ||
| Q1 25 | $-0.08 | $0.63 | ||
| Q4 24 | $-0.07 | $0.82 | ||
| Q3 24 | $-0.09 | $0.70 | ||
| Q2 24 | $-0.13 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $370.7M | $391.5M |
| 总资产 | $829.3M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ALKTRIGL
| Q1 26 | $40.4M | — | ||
| Q4 25 | $63.5M | $155.0M | ||
| Q3 25 | $57.3M | $137.1M | ||
| Q2 25 | $52.4M | $108.4M | ||
| Q1 25 | $61.7M | $77.1M | ||
| Q4 24 | $94.4M | $77.3M | ||
| Q3 24 | $81.0M | $61.1M | ||
| Q2 24 | $61.4M | $49.1M |
总债务ALKTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益ALKTRIGL
| Q1 26 | $370.7M | — | ||
| Q4 25 | $362.0M | $391.5M | ||
| Q3 25 | $350.1M | $117.6M | ||
| Q2 25 | $344.0M | $81.9M | ||
| Q1 25 | $334.0M | $18.6M | ||
| Q4 24 | $357.0M | $3.3M | ||
| Q3 24 | $338.5M | $-14.6M | ||
| Q2 24 | $327.2M | $-29.9M |
总资产ALKTRIGL
| Q1 26 | $829.3M | — | ||
| Q4 25 | $847.2M | $513.6M | ||
| Q3 25 | $835.2M | $242.5M | ||
| Q2 25 | $840.4M | $206.7M | ||
| Q1 25 | $837.2M | $176.0M | ||
| Q4 24 | $437.3M | $164.0M | ||
| Q3 24 | $422.2M | $139.4M | ||
| Q2 24 | $403.9M | $128.4M |
负债/权益比ALKTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-7.4M | — |
| 自由现金流率自由现金流/营收 | -5.8% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $40.1M | — |
8季度趋势，按日历期对齐
经营现金流ALKTRIGL
| Q1 26 | $-4.8M | — | ||
| Q4 25 | $16.6M | $22.0M | ||
| Q3 25 | $30.8M | $24.0M | ||
| Q2 25 | $1.2M | $30.5M | ||
| Q1 25 | $-5.7M | $-893.0K | ||
| Q4 24 | $6.1M | $14.5M | ||
| Q3 24 | $11.0M | $21.7M | ||
| Q2 24 | $548.0K | $302.0K |
自由现金流ALKTRIGL
| Q1 26 | $-7.4M | — | ||
| Q4 25 | $16.2M | — | ||
| Q3 25 | $30.5M | — | ||
| Q2 25 | $760.0K | — | ||
| Q1 25 | $-6.1M | — | ||
| Q4 24 | $6.0M | — | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $123.0K | — |
自由现金流率ALKTRIGL
| Q1 26 | -5.8% | — | ||
| Q4 25 | 13.4% | — | ||
| Q3 25 | 27.0% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -6.3% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 0.1% | — |
资本支出强度ALKTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.5% | — |
现金转化率ALKTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
